SPI1 and acute myeloid leukemia: While deletion of the PU. 1 gene completely abrogates myeloid and/or lymphoid development in mice, transgenic disruption of the upstream regulatory element (URE) results in ~80% reduction of PU.1 level and AML [1, 9].